Abstract
Limited data are available on the long-term effects of drug-eluting stents (DES) versus bare-metal stents (BMS) on rates of death, myocardial infarction (MI), and repeat revascularization in patients with left main coronary artery disease. In this observational cohort of the MAINCOMPARE registry,
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
